These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38897543)

  • 1. Right ventricular sizing and pulmonary vascular resistance: How much mass do you need?
    Pasrija C; Holmes SD; Rozenberg KS; Shah A; Taylor B; Shah A; Trahanas J
    J Thorac Cardiovasc Surg; 2024 Jun; ():. PubMed ID: 38897543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Right ventricular undersizing is associated with increased 1-year mortality.
    Kawabori M; Critsinelis AC; Hironaka CE; Chen FY; Zhan Y; Thayer KL; Couper GS
    J Thorac Cardiovasc Surg; 2021 Mar; 161(3):1048-1059.e3. PubMed ID: 33485653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicted heart mass-based size matching among recipients with moderate pulmonary hypertension: Outcomes and sex effect.
    Shah M; Saeed O; Shin J; Murthy S; Sims DB; Vukelic S; Goldstein D; Forest SJ; Jorde UP; Patel SR
    J Heart Lung Transplant; 2020 Jul; 39(7):648-656. PubMed ID: 32085934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of diastolic pulmonary gradient and pulmonary vascular remodeling on survival after left ventricular assist device implantation and heart transplantation.
    Laimoud M; Hakami E; Maghirang MJ; Mohamed T
    Egypt Heart J; 2023 Dec; 75(1):102. PubMed ID: 38117355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of right ventricular-pulmonary arterial coupling and pulmonary vascular resistance in adult patients with uncorrected atrial septal defect.
    Cool CJ; Khalid AF; Sukmadi N; Akbar MR; Setiabudiawan B; Rahayuningsih SE
    BMC Cardiovasc Disord; 2024 Jun; 24(1):297. PubMed ID: 38853261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the New Pulmonary Hypertension Definition on Heart Transplant Outcomes: Expanding the Hemodynamic Risk Profile.
    Crawford TC; Leary PJ; Fraser CD; Suarez-Pierre A; Magruder JT; Baumgartner WA; Zehr KJ; Whitman GJ; Masri SC; Sheikh F; De Marco T; Maron BA; Sharma K; Gilotra NA; Russell SD; Houston BA; Ramu B; Tedford RJ
    Chest; 2020 Jan; 157(1):151-161. PubMed ID: 31446063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Size Matching Using Predicted Heart Mass With Mortality in Heart Transplant Recipients With Obesity or High Pulmonary Vascular Resistance.
    Tao R; Hess TM; Kuchnia A; Hermsen J; Raza F; Dhingra R
    JAMA Netw Open; 2023 Jun; 6(6):e2319191. PubMed ID: 37351886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left Ventricular Assist Devices or Inotropes for Decreasing Pulmonary Vascular Resistance in Patients with Pulmonary Hypertension Listed for Heart Transplantation.
    Al-Kindi SG; Farhoud M; Zacharias M; Ginwalla MB; ElAmm CA; Benatti RD; Oliveira GH
    J Card Fail; 2017 Mar; 23(3):209-215. PubMed ID: 27374840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diastolic Pulmonary Gradient as a Predictor of Right Ventricular Failure After Left Ventricular Assist Device Implantation.
    Alnsasra H; Asleh R; Schettle SD; Pereira NL; Frantz RP; Edwards BS; Clavell AL; Maltais S; Daly RC; Stulak JM; Rosenbaum AN; Behfar A; Kushwaha SS
    J Am Heart Assoc; 2019 Aug; 8(16):e012073. PubMed ID: 31411097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation.
    Butler J; Stankewicz MA; Wu J; Chomsky DB; Howser RL; Khadim G; Davis SF; Pierson RN; Wilson JR
    J Heart Lung Transplant; 2005 Feb; 24(2):170-7. PubMed ID: 15701433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
    Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the practice of using oversized organs for recipients with elevated pulmonary vascular resistance justified?
    Thangappan K; Zafar F; Ahmed HF; Greenberg JW; Ashfaq A; Hirsch R; Chin C; Lehenbauer D; O'Donnell A; Morales DLS
    J Thorac Cardiovasc Surg; 2023 Dec; 166(6):1766-1779. PubMed ID: 36163295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual Pulmonary Vascular Resistance Increase Under Left Ventricular Assist Device Support Predicts Long-Term Cardiac Function After Heart Transplantation.
    Kakuda N; Amiya E; Hatano M; Tsuji M; Bujo C; Ishida J; Yagi H; Saito A; Narita K; Isotani Y; Fujita K; Ando M; Shimada S; Kinoshita O; Ono M; Komuro I
    Front Cardiovasc Med; 2022; 9():904350. PubMed ID: 35722119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of outcomes in mild pulmonary hypertension according to 2022 ESC/ERS Guidelines: the EVIDENCE-PAH UK study.
    Karia N; Howard L; Johnson M; Kiely DG; Lordan J; McCabe C; Pepke-Zaba J; Ong R; Preiss M; Knight D; Muthurangu V; Coghlan JG
    Eur Heart J; 2023 Nov; 44(44):4678-4691. PubMed ID: 37619574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive assessment of pulmonary vascular resistance by Doppler echocardiography.
    Abbas AE; Franey LM; Marwick T; Maeder MT; Kaye DM; Vlahos AP; Serra W; Al-Azizi K; Schiller NB; Lester SJ
    J Am Soc Echocardiogr; 2013 Oct; 26(10):1170-1177. PubMed ID: 23860092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor-recipient predicted heart mass ratio and right ventricular-pulmonary arterial coupling in heart transplant.
    Nazario RA; Goldraich LA; Hastenteufel LCT; Santos ABS; Carrion L; Clausell N
    Eur J Cardiothorac Surg; 2021 Apr; 59(4):847-854. PubMed ID: 33860318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-existing pulmonary hypertension in patients with end-stage heart failure: impact on clinical outcome and hemodynamic follow-up after orthotopic heart transplantation.
    Goland S; Czer LS; Kass RM; De Robertis MA; Mirocha J; Coleman B; Capelli C; Raissi S; Cheng W; Fontana G; Trento A
    J Heart Lung Transplant; 2007 Apr; 26(4):312-8. PubMed ID: 17403470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study.
    von Scheidt W; Costard-Jaeckle A; Stempfle HU; Deng MC; Schwaab B; Haaff B; Naegele H; Mohacsi P; Trautnitz M;
    J Heart Lung Transplant; 2006 Sep; 25(9):1070-6. PubMed ID: 16962468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normalization of right ventricular performance and remodeling evaluated by magnetic resonance imaging at late follow-up of heart transplantation: relationship between function, exercise capacity and pulmonary vascular resistance.
    Bacal F; Pires PV; Moreira LF; Silva CP; Filho JR; Costa UM; Rosário-Neto MA; Avila VM; Cruz FD; Guimarães GV; Issa VS; Ferreira SA; Stolf N; Ramires JA; Bocchi E
    J Heart Lung Transplant; 2005 Dec; 24(12):2031-6. PubMed ID: 16364845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Right Heart Remodeling After Pulmonary Valve Replacement in Patients With Pulmonary Atresia or Critical Stenosis With Intact Ventricular Septum.
    Irwin M; Reynolds L; Binney G; Lipsitz S; Ghelani SJ; Harrild DM; Baird CW; Geva T; Brown DW
    J Am Heart Assoc; 2023 Nov; 12(21):e031090. PubMed ID: 37929755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.